The clinically significant estimated glomerular filtration rate for hyperkalemia

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Clinical Chemistry

Background:

• Reduced glomerular filtration rate (GFR) is a known cardiovascular disease risk factor.
• Accurate GFR assessment and timely chronic kidney disease (CKD) management are crucial.
• The clinical significance of new Japanese eGFR equations regarding hyperkalemia remains unclear.

Purpose of the Study:

• To determine the clinical significance of estimated GFR (eGFR) in Japanese patients concerning hyperkalemia.
• To identify clinically relevant eGFR thresholds for predicting hyperkalemia risk.

Main Methods:

• Analysis of 9,196 patient records from Toranomon Hospital (January-October 2005).
• Hyperkalemia defined as serum potassium ≥ 5 mEq/L or use of potassium binders.
• Multivariate analysis and eGFR-stratified analysis to assess hyperkalemia incidence.

Main Results:

• Reduced eGFR, diabetes, male gender, aging, and renin-angiotensin system inhibitor use were linked to elevated potassium.
• Hyperkalemia incidence significantly increased below eGFR 50 mL/min/1.73 m² (equation 0.741) and 60 mL/min/1.73 m² (equation 194).

Conclusions:

• An eGFR cutoff of 50 mL/min/1.73 m² using equation 0.741 is clinically significant for hyperkalemia risk.
• An eGFR cutoff of 60 mL/min/1.73 m² using equation 194 is appropriate for identifying hyperkalemia risk.